Stock listing
Hanover:RV7 Halozyme Therapeutics, Inc. Aktie
German listing (Hanover) of Halozyme Therapeutics, Inc. · home listing NASDAQ:HALO
Follow Halozyme Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:HALO
$91.35 USD -4.45 (-4.6%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:HALO
- Day range
- $90.79 – $93.55 USDNov 20, 2026
- Volume
- 1.50M sharesNov 20, 2026
- Market cap
- $10.41B USDAt the close on Nov 20, 2026 · price × 114.0M shares outstanding
- 52-week range
- $61.23 – $133.96 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $248.9M USDMedian day 1.86M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:HALO · Home | $91.35 USD | -4.45 (-4.6%) | 1,502,763 | $92.59 | $93.55 | $90.79 | $95.80 | Close on Nov 20, 2026 |
| Frankfurt:RV7 | €84.16 EUR | -2.46 (-2.8%) | 50 | €84.20 | €84.20 | €84.16 | €86.62 | Close on Nov 20, 2026 |
| LSE:0J2O | $92.60 USD | +0.84 (+0.9%) | 167 | $91.83 | $93.49 | $91.83 | $91.76 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:HALO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $91.35 | -4.45 | -4.6% | $92.59 | $93.55 | $90.79 | 1,502,763 | |
| $95.80 | -0.17 | -0.2% | $95.29 | $97.96 | $95.01 | 1,609,281 | |
| $95.97 | -0.53 | -0.5% | $95.99 | $97.01 | $94.93 | 2,041,007 | |
| $96.50 | -3.77 | -3.8% | $101.72 | $101.75 | $96.40 | 2,088,276 | |
| $100.27 | -0.40 | -0.4% | $100.32 | $101.23 | $99.26 | 2,276,201 | |
| $100.67 | -1.01 | -1.0% | $101.58 | $102.08 | $100.27 | 1,430,725 | |
| $101.68 | -1.30 | -1.3% | $101.25 | $102.62 | $99.27 | 2,504,939 | |
| $102.98 | +0.06 | +0.1% | $101.92 | $105.45 | $101.38 | 2,246,877 | |
| $102.92 | -0.71 | -0.7% | $104.47 | $105.48 | $101.04 | 2,926,670 | |
| $103.63 | -19.33 | -15.7% | $117.03 | $118.26 | $102.53 | 6,161,516 | |
| $122.96 | -7.38 | -5.7% | $130.64 | $131.44 | $122.77 | 2,863,794 | |
| $130.34 | +1.72 | +1.3% | $130.81 | $130.98 | $126.86 | 1,589,126 | |
| $128.62 | -0.33 | -0.3% | $128.29 | $131.36 | $128.26 | 1,412,955 | |
| $128.95 | -1.96 | -1.5% | $130.52 | $131.89 | $127.52 | 3,364,009 | |
| $130.91 | -0.27 | -0.2% | $132.66 | $133.96 | $130.31 | 1,402,092 | |
| $131.18 | +1.15 | +0.9% | $131.02 | $132.55 | $130.09 | 1,874,508 | |
| $130.03 | +1.53 | +1.2% | $126.78 | $130.23 | $126.25 | 1,337,163 | |
| $128.50 | +0.49 | +0.4% | $127.21 | $128.65 | $126.13 | 1,698,709 | |
| $128.01 | +2.38 | +1.9% | $126.86 | $128.11 | $126.03 | 1,237,100 | |
| $125.63 | +1.09 | +0.9% | $124.54 | $126.23 | $123.74 | 1,528,614 | |
| $124.54 | -0.29 | -0.2% | $124.72 | $124.91 | $121.62 | 5,097,794 | |
| $124.83 | +0.46 | +0.4% | $123.90 | $125.43 | $122.71 | 1,715,808 | |
| $124.37 | +1.87 | +1.5% | $123.54 | $125.10 | $123.00 | 2,149,245 | |
| $122.50 | +0.66 | +0.5% | $121.72 | $123.60 | $121.69 | 1,894,415 | |
| $121.84 | +0.33 | +0.3% | $122.19 | $122.45 | $120.19 | 2,082,300 | |
| $121.51 | +4.69 | +4.0% | $118.35 | $122.33 | $117.38 | 2,470,000 | |
| $116.82 | +7.20 | +6.6% | $109.90 | $119.21 | $109.42 | 3,769,000 | |
| $109.62 | -1.46 | -1.3% | $111.92 | $111.92 | $108.80 | 1,772,700 | |
| $111.08 | +0.66 | +0.6% | $110.19 | $112.43 | $109.96 | 1,660,300 | |
| $110.42 | +0.58 | +0.5% | $109.70 | $112.65 | $109.70 | 1,845,300 | |
| $109.84 | -0.95 | -0.9% | $109.41 | $110.64 | $107.41 | 2,490,300 | |
| $110.79 | +1.07 | +1.0% | $111.62 | $114.00 | $110.16 | 2,179,300 | |
| $109.72 | +1.41 | +1.3% | $108.87 | $111.25 | $107.43 | 1,774,300 | |
| $108.31 | -1.55 | -1.4% | $109.62 | $109.87 | $107.68 | 1,855,900 | |
| $109.86 | +2.92 | +2.7% | $106.96 | $109.99 | $106.65 | 2,599,800 | |
| $106.94 | -3.46 | -3.1% | $109.93 | $110.50 | $106.84 | 2,329,000 | |
| $110.40 | -1.16 | -1.0% | $111.54 | $112.45 | $110.35 | 3,521,100 | |
| $111.56 | -1.33 | -1.2% | $112.89 | $114.52 | $111.03 | 2,872,900 | |
| $112.89 | -1.01 | -0.9% | $113.34 | $113.94 | $112.10 | 2,236,700 | |
| $113.90 | -1.32 | -1.1% | $115.36 | $115.63 | $113.43 | 1,958,300 | |
| $115.22 | +2.78 | +2.5% | $112.13 | $116.09 | $111.07 | 3,171,600 | |
| $112.44 | -2.69 | -2.3% | $116.85 | $116.85 | $112.18 | 2,702,800 | |
| $115.13 | +3.68 | +3.3% | $111.50 | $115.18 | $110.95 | 4,150,400 | |
| $111.45 | -1.00 | -0.9% | $112.80 | $113.47 | $111.05 | 2,876,800 | |
| $112.45 | +2.77 | +2.5% | $109.72 | $112.66 | $109.38 | 10,183,400 | |
| $109.68 | +1.24 | +1.1% | $107.08 | $110.88 | $106.82 | 1,983,600 | |
| $108.44 | +2.19 | +2.1% | $106.66 | $109.63 | $105.50 | 1,709,900 | |
| $106.25 | -1.69 | -1.6% | $108.14 | $108.14 | $106.14 | 1,055,600 | |
| $107.94 | +0.74 | +0.7% | $108.00 | $108.61 | $106.65 | 912,500 | |
| $107.20 | +0.20 | +0.2% | $107.96 | $108.23 | $106.34 | 861,500 | |
| $107.00 | -0.39 | -0.4% | $106.93 | $107.95 | $106.36 | 1,464,400 | |
| $107.39 | -0.92 | -0.8% | $107.67 | $108.79 | $106.62 | 1,746,300 | |
| $108.31 | -1.88 | -1.7% | $109.00 | $109.96 | $106.07 | 1,625,600 | |
| $110.19 | -0.57 | -0.5% | $109.91 | $111.15 | $109.00 | 1,010,600 | |
| $110.76 | +1.10 | +1.0% | $109.84 | $111.15 | $108.74 | 1,889,600 | |
| $109.66 | +1.94 | +1.8% | $105.84 | $109.76 | $105.48 | 1,619,200 | |
| $107.72 | +1.23 | +1.2% | $107.45 | $108.53 | $106.87 | 1,058,600 | |
| $106.49 | +1.14 | +1.1% | $104.48 | $106.94 | $103.47 | 1,280,000 | |
| $105.35 | -1.57 | -1.5% | $106.45 | $106.81 | $104.70 | 1,681,800 | |
| $106.92 | -0.14 | -0.1% | $106.87 | $107.55 | $106.05 | 1,364,600 | |
| $107.06 | -2.26 | -2.1% | $109.32 | $109.66 | $107.00 | 1,705,800 | |
| $109.32 | +0.68 | +0.6% | $109.33 | $109.55 | $107.55 | 1,598,158 | |
| $108.64 | +0.47 | +0.4% | $108.00 | $109.10 | $106.87 | 2,091,282 | |
| $108.17 | +2.05 | +1.9% | $106.20 | $108.49 | $105.91 | 1,150,300 | |
| $106.12 | -1.50 | -1.4% | $106.41 | $107.44 | $105.20 | 1,577,500 |
- Ticker
- Hanover:RV7
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Hanover
- Currency
- EUR
What changed lately
Latest news release · Nov 19, 2026
Halozyme Provides Update on German Preliminary Injunction Hearing
Latest earnings call · Nov 5, 2026
Halozyme Therapeutics (NASDAQ:HALO) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 5, 2026
Q3 2026 Earnings Presentation
Earnings · 14 slides
Calls
Replays
Halozyme Therapeutics (NASDAQ:HALO) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 4:30 PM ET
Watch TranscriptHalozyme Therapeutics (NASDAQ:HALO) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch TranscriptHalozyme Therapeutics (NASDAQ:HALO) Q1 2026 Earnings Call
Mon, May 11, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Halozyme Provides Update on German Preliminary Injunction Hearing
Nov 19, 2026
Closed $91.35 (-4.6%) on Nov 20, 2026
Halozyme Reaffirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Medicare Drug Price Negotiation Program Final Rule for IPAY 2029
Nov 6, 2026
Closed $103.63 (-15.7%) on Nov 6, 2026
U.S. FDA Approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Co-Formulated with Halozyme's ENHANZE® Technology for the Treatment of Advanced Head and Neck Cancer
Nov 6, 2026
Closed $103.63 (-15.7%) on Nov 6, 2026
Halozyme reports third quarter 2026 results and raises full year 2026 financial guidance
Nov 5, 2026
Closed $103.63 (-15.7%) on Nov 6, 2026
Halozyme to Report Third Quarter 2026 Financial and Operating Results
Oct 22, 2026
Closed $124.54 (-0.2%) on Oct 22, 2026
Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda SC in Multiple European Markets
Oct 7, 2026
Closed $110.79 (+1.0%) on Oct 7, 2026
Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx to Support the Development of Subcutaneous Formulations for Two Additional Exclusive Targets Using its ENHANZE® Technology
Oct 6, 2026
Closed $110.79 (+1.0%) on Oct 7, 2026
Halozyme Announces Appointment of Jim Daly to its Board of Directors
Sep 30, 2026
Closed $106.94 (-3.1%) on Oct 1, 2026
Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033
Sep 17, 2026
Closed $112.45 (+2.5%) on Sep 18, 2026
Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033
Sep 16, 2026
Closed $109.68 (+1.1%) on Sep 17, 2026
Financings
1.50% convertible senior notes due 2033
Sep 18, 2026
Made bigger: US$1.3B
Use of proceeds: About $162.5 million to fund the cost of capped call transactions
0% convertible senior notes due 2031
Nov 6, 2025
Update: US$650M
Use of proceeds: Fund capped call transactions, repurchase existing 2027 and 2028 convertible notes, and general corporate purposes
0.875% convertible senior notes due 2032
Nov 6, 2025
Update: US$650M
Use of proceeds: Fund capped call transactions, repurchase existing 2027 and 2028 convertible notes, and general corporate purposes
Decks
Q3 2026 Earnings Presentation
Earnings · 14 slides · Nov 5, 2026
Q2 2026 Earnings Presentation
Earnings · 15 slides · Aug 6, 2026
Q1 2026 Earnings Presentation
Earnings · 17 slides · May 11, 2026
FY2025 Earnings Presentation
Earnings · 18 slides · Feb 17, 2026
Halozyme Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 40 in the last 12 months · 224 in all · newest Nov 19, 2026 · oldest 2019
- Calls
- 27 calls with a replay · 27 with a transcript · latest Nov 5, 2026
- Decks
- 66 decks · latest Nov 5, 2026
Where Halozyme Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:HALO · Home listing | NASDAQ | United States | USD |
| gettex:RV7 | gettex | Germany | EUR |
| Tradegate:RV7 | Tradegate | Germany | EUR |
| LS Exchange:A0DLHS | LS Exchange | Germany | EUR |
| BOATS:HALO | BOATS | United States | USD |
| Frankfurt:RV7 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A0DLHS | Lang & Schwarz | Germany | EUR |
| BMV:HALO | BMV | Mexico | MXN |
| LSE:0J2O | LSE | United Kingdom | USD |
| Milan:1HALO | Milan | Italy | EUR |
| BIVA:HALO | BIVA | Mexico | MXN |
| BX Swiss:RV7 | BX Swiss | Switzerland | CHF |
| Dusseldorf:RV7 | Dusseldorf | Germany | EUR |
| Hamburg:RV7 | Hamburg | Germany | EUR |
| Munich:RV7 | Munich | Germany | EUR |
| Stuttgart:RV7 | Stuttgart | Germany | EUR |
| Hanover:RV7 · This page | Hanover | Germany | EUR |
| Xetra:RV7 | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Halozyme Therapeutics, Inc.